James Shell
James Shell
Send Message
James Shell
Stop FollowingJames Shell
View as an RSS Feed
View James Shell's Articles BY TICKER:
- Dissection Of American Capital Agency's And Annaly Capital Management's Q4 Earnings Announcements
-
AbbVie: Don't Fear The Humira Patent Expiration
- AbbVie: Cash Out, Hold Or Reinvest?
- The Abbott Labs/AbbVie Split Strategy: Cash Out, Hold, Reinvest?
- The Real Opportunity In The Two Harbors/Silver Bay IPO
- Update: The Current Value Of Phillips 66
- The Upside Of Annaly's Forward Business Plan
-
Dissecting The Third Quarter American Capital Agency And Annaly Capital Management Earnings Releases
- Analysis: The American Capital Agency And Annaly Capital Management Share Buybacks
- Sandy's Potential Effects And Trading Opportunities For Oil Infrastructure
- Coping With Mortgage REIT Chaos Part II: Additional Thoughts
- Coping With Mortgage REIT Chaos
- The West Coast Fuel Crisis: Origins, Opportunities, Lessons For The Future
- Mortgage REITs And Risk Management
- The Case For Resource Capital Corporation
-
Annaly Capital Management: The Safety Premium Of Preferred Stock
- Revisionist Thinking On Dynex Capital
- Analysis: Another Good Refinery Deal For Calumet
- The Value Of Phillips 66
-
There's Still Upside In The Tesoro/BP Refinery Deal
- The Future Price Of American Capital Agency
- An Earnings Review Of The American Capital Agency And Annaly Capital Management
- The Numbers On The Latest Armour Residential REIT Public Offering.
- The Ethanol Disaster And The Ramifications For Producers
- Update: CVR Partners And Corn Prices
- The Future Price Of American Capital Agency
-
Invesco Mortgage Capital: Dump, Hold Or Reinvest?
- Strategy Update: Armour Residential REIT And Chimera Investment Corporation
- The Other Shoe Drops For Calumet
- Don't Worry About Abbott Labs' Dividend
- mREITs As A Proxy For Residential Real Estate
- The Intriguing Story Of CVR Partners
